| Net Cash Provided by (Used in) Operating Activities |
2.01M |
USD |
|
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
-619K |
USD |
-1562% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
4.72M |
USD |
-5.14% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
50M |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
17.9M |
shares |
+3.58% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
5.97M |
USD |
+275% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
51.4M |
USD |
+11.8% |
Q3 2025 |
Q3 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
1.65K |
USD |
-17.3% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
16.4M |
USD |
-39.5% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Gross |
16.5M |
USD |
-39.2% |
Q4 2024 |
FY 2024 |
| Depreciation |
91.4K |
USD |
-19.9% |
Q3 2025 |
Q3 2025 |
| Payments to Acquire Property, Plant, and Equipment |
4.03K |
USD |
-72.8% |
Q1 2025 |
Q1 2025 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
-3.34M |
USD |
+78.2% |
Q3 2025 |
Q3 2025 |
| Property, Plant and Equipment, Gross |
316K |
USD |
-3.95% |
Q3 2025 |
Q3 2025 |
| Deferred Income Tax Expense (Benefit) |
-18.8K |
USD |
|
Q1 2024 |
Q1 2024 |
| Deferred Tax Assets, Operating Loss Carryforwards |
14.4M |
USD |
-45.5% |
Q4 2024 |
FY 2024 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Authorized |
10M |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Additional Paid in Capital |
155M |
USD |
+0.78% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q3 2025 |
Q3 2025 |
| Amortization of Intangible Assets |
79.7K |
USD |
|
Q3 2024 |
Q3 2025 |
| Depreciation, Depletion and Amortization |
950K |
USD |
+17.4% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
25.2K |
USD |
-76.6% |
Q4 2023 |
FY 2023 |
| Share-based Payment Arrangement, Expense |
1.5M |
USD |
-43% |
Q3 2025 |
Q3 2025 |
| Interest Expense |
7.51K |
USD |
+101% |
Q2 2024 |
Q1 2024 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |